Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Not yet recruiting 2Active not recruiting 2Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Other 1

Conditions

Endometrial Neoplasms 2Endometrial Hyperplasia 2Turcot syndrome 1Overweight 1Obesity 1Neoplasms 1Carcinoma, Endometrioid 1Breast Neoplasms 1Breast Cancer Patients Treated With T-DXd 1

Interventions

Tirzepatide 2Megestrol Acetate 2semaglutide 1Surveys and Questionnaires 1Restraint, Physical 1Resistance Training 1Progestins 1Nutrition Assessment 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Intrauterine Devices 1Hysteroscopy 1Hysterectomy 1Estrogen Replacement Therapy 1Curettage 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Endometrial Hyperplasia × Megestrol Acetate × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

NCT07436793 2026-02-27

Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial

New Mexico Cancer Research Alliance

Phase 2 Not yet recruiting
140 enrolled
Gynecologic

Endometrial Hyperplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡